Ledger.Open graph →
SEC Form D · filed October 16, 2013

Swift Biosciences, Inc

Offering
$7.0M
Sold
$7.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
ANN ARBOR, MI
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Alan W. Djanogly · London, United KingdomDirectorWilliam D. Cohen · Armonk, NYDirectorJustin W. Slatky · New York, NYDirectorValara Capital Management, LLC · Armonk, NYExec · DirectorDavid Olson · Ann Arbor, MIExec · DirectorRobert D. Simmons · Armonk, NYDirectorGeorge Evans · Whitehouse Station, NJDirectorJohn Phinney · Wilton, CTDirectorRashid Bashir · Champaign, ILExec · DirectorBobby Reddy · Champaign, ILDirectorGregg Moskowitz · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗